Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure

scientific article published on 30 May 2018

Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.DADM.2018.05.003
P8608Fatcat IDrelease_lnfq4w4eonhvnemblznph3bzl4
P932PMC publication ID6072672
P698PubMed publication ID30094328

P50authorLu HuQ87713031
P2093author name stringEric McDade
Jennifer H Lingler
Oscar L Lopez
Hyejin Kim
J Scott Roberts
Jonna L Morris
Meghan Mattos
P2860cites workA rating scale for depressionQ24564540
Living With Ambiguity: A Metasynthesis of Qualitative Research on Mild Cognitive ImpairmentQ26796506
Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research ResultsQ27345258
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseQ29614406
Communicating mild cognitive impairment diagnoses with and without amyloid imagingQ33640373
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.Q33792616
Unwarranted variations in healthcare delivery: implications for academic medical centresQ33812581
Amnestic MCI Patients' Perspectives toward Disclosure of Amyloid PET Results in a Research Context.Q33840562
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trialsQ35400583
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, CanadaQ35541638
Development of a process to disclose amyloid imaging results to cognitively normal older adult research participantsQ35595661
Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issuesQ35838385
A Survey of Knowledge and Views Concerning Genetic and Amyloid PET Status DisclosureQ36719734
Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive ImpairmentQ36883137
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerationsQ36929890
Disclosure of amyloid imaging results to research participants: has the time come?Q37135140
Psychometric Properties of a Decisional Capacity Screening Tool for Individuals Contemplating Participation in Alzheimer's Disease ResearchQ37283104
Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.Q38691914
Dyadic Analysis of Illness Perceptions Among Persons with Mild Cognitive Impairment and Their Family MembersQ39000411
Patient and caregiver reactions to clinical amyloid imaging.Q39160016
Confidentiality in preclinical Alzheimer disease studies: when research and medical records meetQ42006679
A new brief instrument for assessing decisional capacity for clinical researchQ46107319
Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET ImagingQ46431433
Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older AdultsQ47742387
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.Q52004978
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Q52589491
Invisible risks, emotional choices--mammography and medical decision makingQ85795417
P407language of work or nameEnglishQ1860
P921main subjectpositron emission tomographyQ208376
P304page(s)413-420
P577publication date2018-05-30
P1433published inAlzheimer's & dementia (Amsterdam, Netherlands)Q27726390
P1476titleAmyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure
P478volume10

Reverse relations

cites work (P2860)
Q92463647Clinician-patient communication during the diagnostic workup: The ABIDE project
Q89744023How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?

Search more.